COMPARISON OF INTUBATING CONDITIONS AFTER ADMINISTRATION OF ORG 9426 (ROCURONIUM) AND SUXAMETHONIUM

被引:162
作者
COOPER, R
MIRAKHUR, RK
CLARKE, RSJ
BOULES, Z
机构
[1] QUEENS UNIV BELFAST,DEPT ANAESTHET,WHITLA MED BLDG,97 LISBURN RD,BELFAST BT9 7BL,ANTRIM,NORTH IRELAND
[2] ROYAL VICTORIA HOSP,DEPT ANAESTHET,BELFAST BT12 6BA,NORTH IRELAND
关键词
ANESTHESIA; INTUBATING CONDITIONS; NEUROMUSCULAR RELAXANTS; SUXAMETHONIUM; ORG 9426 (ROCURONIUM);
D O I
10.1093/bja/69.3.269
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
We have assessed intubating conditions after administration of Org 9426 (rocuronium) 600-mu-g kg-1 at 60 or 90 s in groups of 20 patients anaesthetized with thiopentone, nitrous oxide in oxygen and small doses of fentanyl, and compared the data with those obtained after suxamethonium 1 mg kg-1 in similar groups of patients. The influence fluence of prior suxamethonium administration on the potency of Org 9426 was studied also by constructing a dose-response curve. Intubating conditions after Org 9426 were found to be clinically acceptable (good or excellent) in 95% of patients at 60 s and in all patients at 90 s and in all patients at both times after suxamethonium. The average time for the onset of block following Org 9426 at this dose was 89 s (which is shorter than with any of the currently available non-depolarizing neuromuscular blocking drugs); the duration of clinical relaxation (25% recovery of twitch height) 30 min. Prior administration of suxamethonium did not appear to influence the potency of Org 9426.
引用
收藏
页码:269 / 273
页数:5
相关论文
共 26 条
  • [11] HILGENBERG JC, 1983, ANESTH ANALG, V62, P524
  • [12] INTUBATION CONDITIONS AND REVERSIBILITY OF A NEW NON-DEPOLARIZING NEUROMUSCULAR BLOCKING-AGENT, ORG-NC45
    KRIEG, N
    MAZUR, L
    BOOIJ, LHDJ
    CRUL, JF
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1980, 24 (05) : 423 - 425
  • [13] INFLUENCE OF SUXAMETHONIUM ON THE POTENCY OF ORG-NC-45 IN ANESTHETIZED PATIENTS
    KRIEG, N
    HENDRICKX, HHL
    CRUL, JF
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 1981, 53 (03) : 259 - 262
  • [14] LAPEYRE G, 1990, Anesthesiology (Hagerstown), V73, pA906
  • [15] EXPERIMENTAL AND CLINICAL EXPERIENCES WITH A NEW MUSCLE RELAXANT RO 4-3816, DIALLYL-NOR-TOXIFERINE
    LUND, I
    STOVNER, J
    [J]. ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1962, 6 (02) : 85 - &
  • [16] CLINICAL-PHARMACOLOGY OF VECURONIUM AND ATRACURIUM
    MILLER, RD
    RUPP, SM
    FISHER, DM
    CRONNELLY, R
    FAHEY, MR
    SOHN, YJ
    [J]. ANESTHESIOLOGY, 1984, 61 (04) : 444 - 453
  • [17] CLINICAL-EVALUATION OF ORG-NC-45
    MIRAKHUR, RK
    FERRES, CJ
    CLARKE, RSJ
    BALI, IM
    DUNDEE, JW
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 1983, 55 (02) : 119 - 124
  • [18] MIRAKHUR RK, 1985, ANAESTHESIA, V48, P801
  • [19] EFFECTS OF A NEW NEUROMUSCULAR BLOCKING-AGENT (ORG-9426) IN ANESTHETIZED CATS AND PIGS AND IN ISOLATED NERVE MUSCLE PREPARATIONS
    MUIR, AW
    HOUSTON, J
    GREEN, KL
    MARSHALL, RJ
    BOWMAN, WC
    MARSHALL, IG
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 1989, 63 (04) : 400 - 410
  • [20] Plaud E, 1991, ANESTHESIOLOGY, V75, pA784